People: Biomerica Inc (BMRA.OB)

BMRA.OB on OTC BB

0.86USD
22 Aug 2014
Price Change (% chg)

$-0.06 (-6.52%)
Prev Close
$0.92
Open
$0.86
Day's High
$0.86
Day's Low
$0.86
Volume
5,070
Avg. Vol
8,123
52-wk High
$1.10
52-wk Low
$0.69

Search Stocks

Summary

Name Age Since Current Position

Zackary Irani

47 1997 Chairman of the Board, Chief Executive Officer

Janet Moore

62 1999 Chief Financial Officer, Treasurer, Secretary, Director

Francis Capitanio

69 2000 President - Diagnostics Division

Allen Barbieri

55 1999 Independent Director

Francis Cano

66 1999 Independent Director

Jane Emerson

59 2007 Independent Director

Biographies

Name Description

Zackary Irani

Mr. Zackary Irani is Chairman of the Board, Chief Executive Officer of Biomerica, Inc. Mr. Zackary Irani has been a Director of the Company, and has been serving as the Company's Chairman of the Board and Chief Executive Officer since April 29, 1997. Prior to that time, Mr. Irani served as the Company's Vice President of Business Development. He has been an employee of the Company since 1986. During fiscal 2008 and 2009, Mr. Irani also served as Chairman of the Board of Lancer Orthodontics, Inc. and served as Lancer's Chief Executive Officer from April 1997 until April 2004.

Janet Moore

Ms. Janet Moore is Secretary, Chief Financial Officer, Treasurer and Director of Biomerica, Inc. Ms. Janet Moore has been a Director of the Company since April 29, 1997, and has been serving as the Company's Secretary and Treasurer since 1985. She has served as the Company's Chief Financial Officer since 1999 and has been an employee of the Company since 1976. During fiscal 2008 and through September 29, 2008, Ms. Moore also served as a director and Secretary of Lancer Orthodontics, Inc.

Francis Capitanio

Mr. Francis Capitanio is President - Diagnostics Division of Biomerica, Inc. Mr. Capitanio was President and Chief Executive Officer of Kalisto Biologicals, Inc. from 1997 until 2000. From 1980 until 1996, he was President and Chief Executive Officer of Diatech Diagnostics.

Allen Barbieri

Mr. Allen Barbieri is Independent Director of Biomerica, Inc. Mr. Barbieri currently serves as the CEO of Biosynthetic Technologies, a privately held renewable lubricants manufacturing company. Prior to that, from April 2004 to September 2009, Mr. Barbieri served as the Chief Executive Officer of Lancer Orthodontics, Inc. and from 1999 until the present time Mr. Barbieri has also worked as a private investor. From 1998 to 1999, he served as President and Chief Financial Officer of Buy.com. From 1994 until 1998, Mr. Barbieri was President and Chief Executive Officer of Pacific National Bank.

Francis Cano

Dr. Francis R. Cano, Ph.D., is Independent Director of Biomerica, Inc. Dr. Cano is the managing director of Cano Biotechnology, a thirteen year old consulting business which is focused on vaccines and immunotherapeutics. He co-founded Aviron in 1993 and served as the President and Chief Operating Officer. The Company developed an intranasal flu vaccine and was acquired by MedImmune in 2002 for $1.2 billion. From 1972-1993 Dr. Cano held various scientific/management positions with American Cyanamid, the last of which was as Vice President-General Manager of the Lederle-Praxis Biological Division. During fiscal 2008 and through September 29, 2008, Dr. Cano also served on the board of Lancer Orthodontics, Inc., and currently serves on the board of Arbor Vita Corporation and Dynavax.

Jane Emerson

Dr. Jane Emerson, M.D., Ph.D., is Independent Director of Biomerica, Inc. Since July 1, 2009 Dr. Emerson has served as Chief of Clinical Pathology at the USC Keck School of Medicine, Los Angeles, California. From 1994 to 2009 Dr. Emerson served as Chief, Division of Clinical Pathology for the University of California, Irvine. From 2000 to 2009 she also served as the Chief of Clinical Pathology and from 2004 to 2009 as a Clinical Professor for the University of California, Irvine. From 2005 to 2009 Dr. Emerson served as Vice Chair for Clinical Programs, Department of Pathology and Laboratory Medicine for the University of California, Irvine.

Basic Compensation

Name Fiscal Year Total

Zackary Irani

142,800

Janet Moore

106,872

Francis Capitanio

142,046

Allen Barbieri

--

Francis Cano

--

Jane Emerson

--
As Of 30 May 2013

Options Compensation

Name Options Value

Zackary Irani

430,000 33,500

Janet Moore

0 0

Francis Capitanio

164,000 3,000

Allen Barbieri

0 0

Francis Cano

0 0

Jane Emerson

0 0
Search Stocks